Inventors:
Brian Seed - Boston MA, US
Yi Yang - Cambridge MA, US
Assignee:
The General Hospital Corporation - Boston MA
International Classification:
A01K 67/00, A01K 67/033, A01K 67/027
Abstract:
The present invention features novel methods for generating cell lines and mammals with site-specific genetic modifications of interest. The methods involve homologous recombination between an artificial chromosome having a modification of interest and an endogenous chromosome of a cell. The resulting modified cells can be used in standard methods to generate genetically modified mammals. These mammals can be used in a variety of screening methods to identify compounds useful for the treatment or prevention of disease. Additionally, cells that have been modified to eliminate a mutation associated with a disease can be transplanted into patients for the treatment of a disease.